RUNX2 and ductal breast carcinoma in situ: A low incidence of multifocal ductal carcinoma in situ (DCIS, n=3/47; 6%) was observed in MMTV-Runx2 females (Fig. 6D), whereas no DCIS were seen in control glands (0/33).